Pfizer : PFE

All Pfizer Articles

1508 Articles

Jon C. Ogg | Feb 13, 2012 at 4:17 PM EST

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. …

Douglas A. McIntyre | Feb 2, 2012 at 4:10 AM EST

Media Digest (2/2/2012) Reuters, WSJ, NYT, FT, Bloomberg

Glencore and Xstrata are in merger talks. (Reuters) A federal mortgage deal with banks over mortgage fraud would give states enforcement…

Jon C. Ogg | Feb 1, 2012 at 4:39 PM EST

Pfizer Recalls Birth Control Pills (PFE)

There is going to be some concerning news if you are on birth control pills made by Pfizer Inc. (NYSE:…

Paul Ausick | Jan 31, 2012 at 4:06 PM EST

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to…

Jon C. Ogg | Jan 31, 2012 at 7:17 AM EST

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s…

Jon C. Ogg | Jan 30, 2012 at 1:26 PM EST

10 Major Earnings Previews For Tuesday (AMZN, ARMH, BIIB, BRCM, XOM, PFE, STX, UPS, X, VLO)

Tuesday is going to be full of major earnings reports, two of which are DJIA components. These are not the…

Paul Ausick | Jan 27, 2012 at 2:34 PM EST

Pfizer Gets Okay for New Drug (PFE)

Pfizer Inc. (NYSE: PFE) has received approval from the US Food and Drug Administration to sell its kidney cancer drug,…

Jon C. Ogg | Jan 23, 2012 at 6:33 PM EST

Cramer Now Touts Merck For Drug & Yield (MRK, PFE)

Jim Cramer has touted several DJIA upside calls in 2012, but on Monday’s MAD MONEY on CNBC Cramer touted Merck…

Paul Ausick | Jan 11, 2012 at 1:37 PM EST

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…

Paul Ausick | Jan 4, 2012 at 12:45 PM EST

Pfizer Loses Court Case on Menopause Drug (PFE)

A state appeals court in Pennsylvania has sided with two women who filed suit against drugmaker Pfizer Inc. (NYSE: PFE)…

Jon C. Ogg | Jan 4, 2012 at 8:01 AM EST

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at…

Jon C. Ogg | Jan 3, 2012 at 6:40 AM EST

DJIA 2012: Best Targets Imply DJIA 13,678 (BAC, JPM, VZ, IBM, CVX, MCD, CSCO, XOM, GE, HPQ, INTC, MRK, PFE, PG, WMT, DIA)

As each new year replaces the prior year, 24/7 Wall St. looks at the individual targets on all 30 Dow…

Jon C. Ogg | Dec 29, 2011 at 1:02 PM EST

Which Dogs of the Dow Are Best in 2012? (T, VZ, MRK, PFE, GE, DD, JNJ, INTC, PG, MSFT, CVX, JPM, KFT, MCD)

The lineup of the Dogs of the Dow, simply the ten highest dividend yield stocks of the thirty Dow Jones…

Jon C. Ogg | Dec 20, 2011 at 8:01 AM EST

Even More DJIA Dividend Hikes Coming Soon (BA, GE, DIS, T, PFE, CSCO, KO, XOM, IBM, JNJ, JPM, MMM, WMT, DVY, VIG, PFM, HDV)

Throughout December we have been giving updates on dividends that will rise in the coming days and weeks from the…

Paul Ausick | Dec 19, 2011 at 1:37 PM EST

Ad Spending Growth Slows (PG, T, PFE, GM, GOOG, YHOO)

Spending on advertising barely showed a pulse in the third quarter of 2011, growing by just 0.4%, according a report…

1 … 78 79 80 81 82 … 101

Pfizer : PFE

All Pfizer Articles

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

Media Digest (2/2/2012) Reuters, WSJ, NYT, FT, Bloomberg

Pfizer Recalls Birth Control Pills (PFE)

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

10 Major Earnings Previews For Tuesday (AMZN, ARMH, BIIB, BRCM, XOM, PFE, STX, UPS, X, VLO)

Pfizer Gets Okay for New Drug (PFE)

Cramer Now Touts Merck For Drug & Yield (MRK, PFE)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Pfizer Loses Court Case on Menopause Drug (PFE)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

DJIA 2012: Best Targets Imply DJIA 13,678 (BAC, JPM, VZ, IBM, CVX, MCD, CSCO, XOM, GE, HPQ, INTC, MRK, PFE, PG, WMT, DIA)

Which Dogs of the Dow Are Best in 2012? (T, VZ, MRK, PFE, GE, DD, JNJ, INTC, PG, MSFT, CVX, JPM, KFT, MCD)

Even More DJIA Dividend Hikes Coming Soon (BA, GE, DIS, T, PFE, CSCO, KO, XOM, IBM, JNJ, JPM, MMM, WMT, DVY, VIG, PFM, HDV)

Ad Spending Growth Slows (PG, T, PFE, GM, GOOG, YHOO)

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse’s Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse's Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

Pfizer : PFE

All Pfizer Articles

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

Media Digest (2/2/2012) Reuters, WSJ, NYT, FT, Bloomberg

Pfizer Recalls Birth Control Pills (PFE)

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

10 Major Earnings Previews For Tuesday (AMZN, ARMH, BIIB, BRCM, XOM, PFE, STX, UPS, X, VLO)

Pfizer Gets Okay for New Drug (PFE)

Cramer Now Touts Merck For Drug & Yield (MRK, PFE)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Pfizer Loses Court Case on Menopause Drug (PFE)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

DJIA 2012: Best Targets Imply DJIA 13,678 (BAC, JPM, VZ, IBM, CVX, MCD, CSCO, XOM, GE, HPQ, INTC, MRK, PFE, PG, WMT, DIA)

Which Dogs of the Dow Are Best in 2012? (T, VZ, MRK, PFE, GE, DD, JNJ, INTC, PG, MSFT, CVX, JPM, KFT, MCD)

Even More DJIA Dividend Hikes Coming Soon (BA, GE, DIS, T, PFE, CSCO, KO, XOM, IBM, JNJ, JPM, MMM, WMT, DVY, VIG, PFM, HDV)

Ad Spending Growth Slows (PG, T, PFE, GM, GOOG, YHOO)

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse’s Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

Featured Reads

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse's Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.